The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
90 jobs Number of planned job losses
Announcement Date
2 October 2012
Employment effect (start)
Foreseen end date
30 April 2013
Description
Merck Sharp and Dohme (MSD), which produces pharmaceutical products for the global healthcare industry, has announced 90 redundancies at its Cork plant in Ireland. The job losses are expected to occur over the next six months. The company said the redundancies are required due to declining demand for products from the plant.
MSD employs 2,300 staff across Ireland in Carlow, Cork, Dublin, Tipperary and Wicklow and manufactures prescription medicines, vaccines, biologic therapies, consumer care and animal health products. The Cork plant opened in 1980 and employs 455 staff.
Sources
3 October 2012: The Irish Independent
Citation
Eurofound (2012), Merck Sharp and Dohme, Internal restructuring in Ireland, factsheet number 74268, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/74268.